» Articles » PMID: 33243086

Assessing COVID-19 Susceptibility Through Analysis of the Genetic and Epigenetic Diversity of ACE2-mediated SARS-CoV-2 Entry

Overview
Specialties Genetics
Pharmacology
Date 2020 Nov 27
PMID 33243086
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

There is considerable variation in disease course among individuals infected with SARS-CoV-2. Many of them do not exhibit any symptoms, while some others proceed to develop COVID-19; however, severity of COVID-19 symptoms greatly differs among individuals. Focusing on the early events related to SARS-CoV-2 entry to cells through the ACE2 pathway, we describe how variability in (epi)genetic factors can conceivably explain variability in disease course. We specifically focus on variations in , and genes, as central components for SARS-CoV-2 infection, and on other molecules that modulate their expression such as , , and  We propose a genetic classifier for predicting SARS-CoV-2 infectivity potential as a preliminary tool for identifying the at-risk-population. This tool can serve as a dynamic scaffold being updated and adapted to validated (epi)genetic data. Overall, the proposed approach holds potential for better personalization of COVID-19 handling.

Citing Articles

The COVID-19 legacy: consequences for the human DNA methylome and therapeutic perspectives.

Gaetano C, Atlante S, Gottardi Zamperla M, Barbi V, Gentilini D, Illi B Geroscience. 2024; 47(1):483-501.

PMID: 39497009 PMC: 11872859. DOI: 10.1007/s11357-024-01406-7.


ACE2 receptor polymorphism in humans and animals increases the risk of the emergence of SARS-CoV-2 variants during repeated intra- and inter-species host-switching of the virus.

Devaux C, Fantini J Front Microbiol. 2023; 14:1199561.

PMID: 37520374 PMC: 10373931. DOI: 10.3389/fmicb.2023.1199561.


Involvement of epigenetics in affecting host immunity during SARS-CoV-2 infection.

Behura A, Naik L, Patel S, Das M, Kumar A, Mishra A Biochim Biophys Acta Mol Basis Dis. 2022; 1869(3):166634.

PMID: 36577469 PMC: 9790847. DOI: 10.1016/j.bbadis.2022.166634.


Premenopausal and postmenopausal women during the COVID-19 pandemic.

Pertynska-Marczewska M, Pertynski T Prz Menopauzalny. 2022; 21(3):200-206.

PMID: 36254124 PMC: 9551364. DOI: 10.5114/pm.2022.118695.


Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework.

Clerbaux L, Albertini M, Amigo N, Beronius A, Bezemer G, Coecke S J Clin Med. 2022; 11(15).

PMID: 35956081 PMC: 9369763. DOI: 10.3390/jcm11154464.


References
1.
Lambert D, Clarke N, Hooper N, Turner A . Calmodulin interacts with angiotensin-converting enzyme-2 (ACE2) and inhibits shedding of its ectodomain. FEBS Lett. 2007; 582(2):385-90. PMC: 7094239. DOI: 10.1016/j.febslet.2007.11.085. View

2.
Fan R, Mao S, Gu T, Zhong F, Gong M, Hao L . Preliminary analysis of the association between methylation of the ACE2 promoter and essential hypertension. Mol Med Rep. 2017; 15(6):3905-3911. DOI: 10.3892/mmr.2017.6460. View

3.
Chazin W, Johnson C . Calmodulin Mutations Associated with Heart Arrhythmia: A Status Report. Int J Mol Sci. 2020; 21(4). PMC: 7073091. DOI: 10.3390/ijms21041418. View

4.
Braun E, Sauter D . Furin-mediated protein processing in infectious diseases and cancer. Clin Transl Immunology. 2019; 8(8):e1073. PMC: 6682551. DOI: 10.1002/cti2.1073. View

5.
Hussain M, Jabeen N, Raza F, Shabbir S, Baig A, Amanullah A . Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein. J Med Virol. 2020; 92(9):1580-1586. PMC: 7228372. DOI: 10.1002/jmv.25832. View